BRIAN MURRELL: Open Payments
NPI 1063694859 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,081 in 88 payments from 24 companies in 2025. Trend: 2023 $2,135 · 2024 $2,573 · 2025 $2,081
Food & beverage: $2,081
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $386 |
| Novo Nordisk Inc | 13 | $227 |
| Amgen Inc. | 11 | $210 |
| Tandem Diabetes Care, Inc. | 4 | $141 |
| SANOFI-AVENTIS U.S. LLC | 6 | $113 |
| Ascendis Pharma Endocrinology Inc | 2 | $109 |
| Mannkind Corporation | 5 | $107 |
| Dexcom, Inc. | 2 | $105 |
| Xeris Pharmaceuticals, Inc. | 5 | $104 |
| BETA BIONICS, INC. | 5 | $103 |
Products named: FREESTYLE LIBRE 3, Ozempic, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, TZIELD, Yorvipath, AFREZZA, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
